Device firms back latest MDUFA deal, while patients want more postmarket safety

The latest Medical Device User Fee Agreement includes higher fees for overseas firms, hiring transparency requirements, and greater use of real-world evidence. The deal addresses FDA regulatory processes and postmarket surveillance for medical devices.